GS-5745 Terminated Phase 2 Trials for Crohn's Disease (CD) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02405442Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease